In today’s market, productivity in both the pharmaceutical and biological industry has dropped together with a record low in drugs not receiving market approval. “despite increasing spend on R&D. Media have criticized the R&D industry for lacking innovation, focusing on “me-too”opportunities and developing drugs that cannot be approved because of unethical marketing or lack of adequate evidence of their effectiveness and safety.

The Annual GDDIF is the forum for senior level discovery and development executives to come together and engage in interactive workshops, intimate panel discussions and network with industry peers to procure and re-examine their challenges & objectives now and in the crucial ears to come.

Our summit is designed with an interactive and engaging format, where influential leaders from around the world and across all the relevant areas, meet to debate and explore with their peers the key technology developments and opportunities at present and in the years ahead.

The summit brings together approximately 120 industry leaders and principle scientists to engage in interactive workshops, panel discussions, and networking sessions to add value in both their key objectives and challenges. GbxSummits has elected 40 of the most influential leaders and forward thinkers in the drug discovery & development realm The delegation is produced on behalf of GbxSummits and invitations are based on the level of responsibility and experience for both the delegate and speaker.

Our unique model has been developed to surpass the traditional exchange of business cards at trade shows and speed meetings events. The leaders summit format is tailored to allow executives bench-mark with other fellow peers, network with leading technology providers on a strategic level whist in an exclusive environment.